Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands.
Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, USA.
Gut. 2019 Apr;68(4):615-622. doi: 10.1136/gutjnl-2017-315440. Epub 2018 May 2.
Surveillance colonoscopy is thought to prevent colorectal cancer (CRC) in patients with long-standing colonic IBD, but data regarding the frequency of surveillance and the findings thereof are lacking. Our aim was to determine whether consecutive negative surveillance colonoscopies adequately predict low neoplastic risk.
A multicentre, multinational database of patients with long-standing IBD colitis without high-risk features and undergoing regular CRC surveillance was constructed. A 'negative' surveillance colonoscopy was predefined as a technically adequate procedure having no postinflammatory polyps, no strictures, no endoscopic disease activity and no evidence of neoplasia; a 'positive' colonoscopy was a technically adequate procedure that included at least one of these criteria. The primary endpoint was advanced colorectal neoplasia (aCRN), defined as high-grade dysplasia or CRC.
Of 775 patients with long-standing IBD colitis, 44% (n=340) had 1 negative colonoscopy. Patients with consecutive negative surveillance colonoscopies were compared with those who had at least one positive colonoscopy. Both groups had similar demographics, disease-related characteristics, number of surveillance colonoscopies and time intervals between colonoscopies. No aCRN occurred in those with consecutive negative surveillance, compared with an incidence rate of 0.29 to 0.76/100 patient-years (P=0.02) in those having 1 positive colonoscopy on follow-up of 6.1 (P25-P75: 4.6-8.2) years after the index procedure.
Within this large surveillance cohort of patients with colonic IBD and no additional high-risk features, having two consecutive negative colonoscopies predicted a very low risk of aCRN occurrence on follow-up. Our findings suggest that longer surveillance intervals in this selected population may be safe.
人们认为,对患有长期结肠 IBD 的患者进行监测性结肠镜检查可以预防结直肠癌(CRC),但缺乏关于监测频率及其结果的数据。我们的目的是确定连续阴性监测结肠镜检查是否能充分预测低肿瘤风险。
建立了一个多中心、多国的数据库,其中包含无高危特征的长期 IBD 结肠炎患者,并进行常规 CRC 监测。将“阴性”监测结肠镜检查定义为技术上充分的程序,没有炎症后息肉、没有狭窄、没有内镜疾病活动且没有肿瘤证据;“阳性”结肠镜检查是指技术上充分的程序,包括至少一个上述标准。主要终点是晚期结直肠肿瘤(aCRN),定义为高级别异型增生或 CRC。
在 775 名患有长期 IBD 结肠炎的患者中,44%(n=340)有 1 次阴性结肠镜检查。将连续阴性监测结肠镜检查的患者与至少有 1 次阳性结肠镜检查的患者进行比较。两组患者的人口统计学特征、疾病相关特征、监测结肠镜检查的数量以及结肠镜检查之间的时间间隔均相似。在连续阴性监测的患者中未发生 aCRN,而在随访期间至少有 1 次阳性结肠镜检查的患者中,aCRN 的发生率为 0.29 至 0.76/100 患者年(P=0.02),在索引手术后 6.1(P25-P75:4.6-8.2)年的随访中。
在这个大型的、患有结肠 IBD 且无其他高危特征的监测队列中,连续两次阴性结肠镜检查预测在随访中发生 aCRN 的风险非常低。我们的研究结果表明,在这个选定的人群中,更长的监测间隔可能是安全的。